Mammogram decision support for women in rural areas
Official title: Toward Optimization of a Mammography Decision Aid and Clinician Communication Intervention Trial for Rural Settings
Run by Dartmouth-Hitchcock Medical Center · NCT06522568 · Data updated 2026-11-12
This pilot will try a patient decision aid, with or without a clinician communication intervention, to help women aged 40–49 in rural primary care decide about mammography.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 39 Years to 49 Years |
| Sex | Women only |
| Enrollment | 39 (estimated) |
| Sponsor | Dartmouth-Hitchcock Medical Center Academic / other |
| Locations | 3 sites (Keene, New Hampshire and 2 other locations) |
| Status | Recruiting |
| Started | September 1, 2025 |
| Main results expected | January 20, 2027 |
| Study ends | January 20, 2027 |
| Registry record updated | September 24, 2026 |
| Trial ID | NCT06522568 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 40–49 who speak English or Spanish, have no prior breast cancer, have not had a mammogram in the past 12 months, and have an upcoming primary care visit at a participating site are eligible.
✕Probably not a fit
Women with a history of breast cancer (including DCIS/LCIS/atypical hyperplasia), those who had a mammogram in the prior 12 months, or those outside the age or language criteria are unlikely to benefit from this pilot.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a three-arm cluster randomized pilot where primary care providers are randomized to usual care, a patient decision aid (MyMammogram), or the decision aid plus a clinician communication intervention. The trial will enroll about 30 eligible women across two phases and use EHR reports to identify patients with upcoming visits. Data collection includes baseline and post-intervention surveys, post-visit surveys, medical-record abstraction for mammography, and implementation measures from both patients and clinicians. The primary focus is feasibility and intervention acceptability, with quantitative summaries of recruitment, retention, adherence, and acceptability metrics.
Why it matters
Potential benefit: If successful, the intervention could improve patient–clinician conversations and help women make informed, preference-aligned decisions about mammography in rural settings.
How similar studies have gone: Previous work with mammography decision aids and clinician communication training has improved knowledge and decision quality, but applying and testing these approaches specifically in rural primary care settings is less well established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Patient Inclusion Criteria: * Females * Aged 39-49 * Upcoming appointment with a participating primary care provider (within 4 weeks) * English or Spanish-speaking Patient Exclusion Criteria: * Personal history of breast cancer (including lobular carcinoma in situ and ductal carcinoma in situ or atypical hyperplasia) * Mammogram in the prior 9 months Clinician inclusion: Any practicing primary care provider at a participating site.
Where it's running
-
Cheshire Medical Center
Keene, New Hampshire, United States Recruiting -
New London Hospital Primary Care
New London, New Hampshire, United States Recruiting -
Newport Health Center
Newport, New Hampshire, United States Recruiting
Study contacts
- Study coordinator: Christine M Gunn, PhD
- Email: Christine.M.Gunn@dartmouth.edu
- Phone: 603-646-5430
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.